Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, renal pelvis/ureter urothelial carcinoma, transitional cell carcinoma, ureter cancer, ureteral disorder, urethra neoplasm, urethral disorder, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder	Recruiting	Phase 2	2025-08-14		NCT06983210

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chiba University	6
Japan Agency for Medical Research and Development	11
Kyoto University	9
Kyushu University	6
Nagoya University	3
University of Tsukuba	4

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Nagoya University Hospital	Nagoya	Japan	2